17047-Breast Cancer-NA-421

Breast Cancer

An Open-Label Phase 2 Study of MLN0128 (A TORC1/2 Inhibitor) in Combination With Fulvestrant in Women With ER-Positive/HER2-Negative Advanced or Metastatic Breast Cancer That Has Progressed During or After Aromatase Inhibitor Therapy. (C31006)

  • Details

ClinicalTrials.gov ID: NCT02756364
Diagnosis Type: NA
USOR Number: 17047

  • Address

3130 SW 32nd Street
Ocala, FL 34471
P: (352) 732-4032

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.